Pee Cee Cosma Sope Ltd

Pee Cee Cosma Sope Ltd

₹ 504 -1.82%
22 May - close price
About

Incorporated in 1986, Pee Cee Cosma Sope
Ltd manufactures Laundry Soap, Detergent
Cake & Powder[1]

Key Points

Business Overview:[1][2]
PCCS is an ISO 9001:2000 certified health hygiene brand which does manufacturing, sale, purchase of detergent cake, cleaning preparation, soap chips, detergent powder and various toiletry and other products, etc. under the Doctor brand

Products & Brands:
a) Laundry Soaps:[3]
Doctor Double Action, Doctor Single Wrapper, Doctor Gre, Doctor Premium, Doctor Shudh, Doctor Super Fine
b) Detergent Powders:[4]
Doctor Advanced, Doctor Ultra, Doctor Washing Powder
c) Detergent Cakes:[5]
Doctor Advanced, Doctor Blue
d) Liquid Soaps:[6]
Doctor Clean

  • Market Cap 134 Cr.
  • Current Price 504
  • High / Low 979 / 385
  • Stock P/E 13.9
  • Book Value 184
  • Dividend Yield 0.59 %
  • ROCE 28.5 %
  • ROE 21.6 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 35.7% CAGR over last 5 years

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: FMCG Industry: Detergents / Intermediates

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
25.33 33.18 28.67 33.05 29.62 36.74 32.57 33.80 30.54 39.85 30.94 34.31 35.48
25.17 32.60 27.91 31.58 27.24 33.07 28.86 29.73 26.64 35.68 27.78 30.08 33.99
Operating Profit 0.16 0.58 0.76 1.47 2.38 3.67 3.71 4.07 3.90 4.17 3.16 4.23 1.49
OPM % 0.63% 1.75% 2.65% 4.45% 8.04% 9.99% 11.39% 12.04% 12.77% 10.46% 10.21% 12.33% 4.20%
0.20 0.15 0.12 0.13 0.13 0.13 0.13 0.13 0.22 0.70 0.82 0.20 0.01
Interest 0.00 0.21 0.28 0.18 0.20 0.14 0.09 0.05 0.03 0.02 0.05 0.09 0.07
Depreciation 0.17 0.32 0.40 0.41 0.37 0.36 0.40 0.41 0.43 0.33 0.39 0.41 0.51
Profit before tax 0.19 0.20 0.20 1.01 1.94 3.30 3.35 3.74 3.66 4.52 3.54 3.93 0.92
Tax % 42.11% 35.00% 15.00% 24.75% 25.26% 26.67% 25.07% 25.13% 25.96% 25.66% 24.58% 24.94% 29.35%
0.11 0.12 0.16 0.75 1.45 2.43 2.51 2.79 2.71 3.35 2.66 2.94 0.65
EPS in Rs 0.42 0.45 0.60 2.83 5.48 9.18 9.48 10.54 10.24 12.66 10.05 11.11 2.46
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
76 80 75 71 76 76 74 82 93 125 134 141
72 77 70 67 70 71 70 76 90 119 118 128
Operating Profit 4 4 5 3 6 5 3 7 3 5 15 13
OPM % 5% 5% 6% 5% 8% 6% 5% 8% 3% 4% 11% 9%
0 0 0 0 0 0 0 1 1 1 1 2
Interest 0 1 1 0 0 0 0 0 0 1 0 0
Depreciation 1 1 1 1 1 1 1 1 1 2 2 2
Profit before tax 3 2 3 2 6 4 3 6 2 3 14 13
Tax % 34% 34% 35% 33% 34% 30% 27% 26% 27% 26% 26% 26%
2 1 2 2 4 3 2 5 2 2 10 10
EPS in Rs 7.10 5.10 7.75 5.82 13.87 10.73 7.97 18.03 6.39 9.41 39.45 36.31
Dividend Payout % 17% 29% 23% 43% 22% 28% 38% 17% 16% 21% 13% 8%
Compounded Sales Growth
10 Years: 6%
5 Years: 14%
3 Years: 15%
TTM: 5%
Compounded Profit Growth
10 Years: 22%
5 Years: 36%
3 Years: 78%
TTM: -8%
Stock Price CAGR
10 Years: 28%
5 Years: 43%
3 Years: 64%
1 Year: 20%
Return on Equity
10 Years: 16%
5 Years: 18%
3 Years: 21%
Last Year: 22%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 3 3 3 3 3 3 3 3 3 3 3 3
Reserves 11 12 13 15 18 20 20 25 26 28 38 46
10 8 6 4 3 3 5 3 14 11 2 2
4 6 5 4 4 4 4 5 5 6 6 8
Total Liabilities 28 28 27 26 27 30 32 36 47 47 48 58
8 8 7 10 9 9 9 9 17 18 18 18
CWIP 0 0 0 0 0 0 0 0 2 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 4 9
19 20 19 16 18 21 23 27 28 28 26 30
Total Assets 28 28 27 26 27 30 32 36 47 47 48 58

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
4 5 1 3 2 1 3 0 9 3 6 7
-0 -1 -0 -0 -0 -0 -1 -0 -11 -1 -1 -6
-6 -4 -1 -3 -2 -1 -1 -2 3 -4 -5 -1
Net Cash Flow -2 0 -0 -0 -0 0 2 -2 1 -1 -0 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 2 2 2 1 2 2 1 2 2 2 1 2
Inventory Days 82 81 85 67 76 79 65 71 62 58 55 63
Days Payable 9 16 9 8 9 9 10 14 9 5 11 15
Cash Conversion Cycle 74 67 78 61 69 72 56 59 54 55 45 50
Working Capital Days 46 35 42 33 41 53 50 33 34 32 24 53
ROCE % 14% 12% 18% 13% 26% 17% 11% 23% 8% 10% 35% 29%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
74.56% 74.56% 74.56% 74.56% 74.56% 74.21% 74.17% 73.07% 73.07% 72.57% 72.58% 72.58%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.78%
25.44% 25.44% 25.43% 25.44% 25.43% 25.80% 25.83% 26.91% 26.92% 27.43% 27.41% 26.64%
No. of Shareholders 2,6822,6622,5452,5432,4832,4342,5522,9172,8773,2973,5643,476

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents